Antigenic sites of foot-and-mouth disease virus (FMDV): An analysis of the specificities of anti-FMDV antibodies after vaccination of naturally susceptible host species

Journal of General Virology

Volumn 83, Issue 4, 2002, Pages 775-782

  Aggarwal, Naeeraj ^a   Barnett, P V ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; FOOT AND MOUTH DISEASE VACCINE; GLYCINE; HISTIDINE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; POLYCLONAL ANTIBODY; POLYCLONAL ANTISERUM; PROTEIN VP1; SAPONIN DERIVATIVE; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANTIBODY COMBINING SITE; ANTIBODY SPECIFICITY; ARTICLE; BOVIDS; CARBOXY TERMINAL SEQUENCE; CATTLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG DESIGN; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; HOST RESISTANCE; IMMUNOGENICITY; INFECTION RESISTANCE; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; SHEEP; SPECIES DIFFERENCE; SWINE; VACCINATION; VACCINE PRODUCTION; VIRUS IMMUNITY; VIRUS STRAIN;

ANIMALIA; BOS TAURUS; BOVIDAE; FOOT-AND-MOUTH DISEASE VIRUS; OVIS ARIES; RNA VIRUSES; SUS SCROFA;

EID: 0036208460     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-83-4-775     Document Type: Article

References (36)

1. 1/Manisa/Turkey/69 using monoclonal antibodies
2. Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus
3. 1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse
4. Neutralization epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites
5. 12 foot-and-mouth disease virus
6. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence
7. Characterisation of foot-and-mouth disease virus antibodies
8. Purification of radioactive foot-and-mouth disease virus
9. Foreign epitopes in immunodominant regions of hepatitis B core particles are highly immunogenic and conformationally restricted
10. Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants
11. Protection of cattle against foot-and-mouth disease by a synthetic peptide
12. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease
13. Extensive antigenic diversification of foot-and-mouth disease virus by amino acid substitutions outside the major antigenic site
14. Analysis of foot-and-mouth disease virus-neutralizing idiotypes from immune bovine and swine with anti-murine idiotype antibody probes
15. Radial immuno-diffusion and serum neutralisation techniques for the assay of antibodies to swine vesicular disease
16. Rapid correlation between field isolates and vaccine strains of foot-and-mouth disease virus
17. Sequence analysis of monoclonal antibody resistant mutants of type O foot-and-mouth disease virus: Evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites
18. Cloned viral protein vaccine for foot-and-mouth disease. Responses in cattle and swine
19. Epitopes on foot-and-mouth disease virus particles. I. Topology
20. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate
21. Antibody recognition of picornaviruses and escape from neutralisation: A structural view
22. A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C
23. Direct evaluation of the immunodominance of a major antigenic site of foot-and-mouth disease virus in a natural host
24. Development of replication-defective Adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate
25. Protection of cattle and swine against foot-and-mouth disease, using biosynthetic peptide vaccines
26. Correlation of 140S antigen dose with the serum neutralising antibody response and the level of protection induced in cattle by foot-and-mouth disease vaccines
27. Antibodies against a preselected peptide recognize and neutralize foot-and-mouth disease virus
28. Genetic and antigenic studies on foot-and-mouth disease virus type O
29. Recombinant viruses expressing the foot-and-mouth disease virus capsid precursor polypeptide (P1) induce cellular but not humoral antiviral immunity and partial protection in pigs
30. Foot-and-mouth disease virus: A long known virus, but a current threat
31. Location and characterization of the antigenic portion of the FMDV immunizing protein
32. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: Lack of solid protection in cattle and isolation of escape mutants
33. 10
34. Evidence for more than one important, neutralizing site on foot-and-mouth disease virus
35. Plasmid DNA encoding replicating foot-and-mouth disease virus genomes induces antiviral immune responses in swine
36. Surface structure of foot-and-mouth disease virus